Slowing down Alzheimer's disease with flashing light
Available treatments for Alzheimer's disease (AD) are ineffective and fail to halt progressive and irreversible brain damage. Recent evidence indicates that non-invasive flashing light can clear amyloid-beta, one of the key pathogenic hallmarks of AD, and offer neural protection. The EU-funded BRIGHT project will conduct a feasibility study for a novel flickering white light therapy that can stimulate the human visual receptors and processing cortex. The white light forms by combining different coloured LEDs and does not cause fatigue like stroboscopic light. The proposed intervention has the potential to delay disease onset, reduce prevalence and associated costs.
Fields of science
Call for proposalSee other projects for this call